BRD2 and ovarian carcinoma: After the MUC16 promoter was introduced into the FSH peptide-conjugated gro-α shRNA nanoparticles, tumor growth was significantly inhibited in a nude mouse model bearing ovarian cancer, and no obvious toxic effects were observed.